| Code | 2770F | ||||||||||
| MA number | 41/0034/26-S | ||||||||||
| Product Form: | tbl flm 14x24 mg/26 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Zaklady Farmaceutyczne POLPHARMA S.A., Poland | ||||||||||
| Therapeutic Class: | 41 - CARDIACA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 12.03.2026 |
| Validity: | 12.03.2031 |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Sacubitril Valsartan Polpharma_02_2026.pdf
|
| SPC: |
SPC_Sacubitril Valsartan Polpharma_02_2026.pdf
|
| Safety feature | Yes |
| Data update: | 12.03.2026 |
